If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennon Regulatory News (PNN)

Share Price Information for Pennon (PNN)

Share Price is delayed by 15 minutes
Get Live Data
485.40    3.80 (0.79%)
Bid:
485.00
Ask:
485.60
Spread: 0.60 (0.124%)
Market Cap: £2.29b
PNN Live PriceLast checked at - London Stock Exchange

Intraday Pennon Share Chart

Result of AGM

22 Jul 2022 17:04

RNS Number : 5101T
Pennon Group PLC
22 July 2022
 

Pennon Group plc

 

Result of the Annual General Meeting held on 21 July 2022 at Peninsula House, Rydon Lane, Exeter EX2 7HR, at 9.30am

 

The Directors are pleased to announce that the shareholders of Pennon Group plc passed all of the resolutions which were set out in the Notice of Annual General Meeting dated 15 June 2022.

 

Voting on all resolutions was conducted by way of a poll and the below table shows the percentage of issued share capital voted for each.

 

A copy of each of the resolutions passed by the Company, other than resolutions concerning ordinary business, will be submitted and made available for inspection on the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism 

 

A copy of this announcement will be posted on the Company's website at www.pennon-group.co.uk/investor-information/shareholder-services

 

 

 

RESOLUTION

VOTES

FOR

%

FOR

VOTES

AGAINST

%

AGAINST

VOTESTOTAL

 

% SHARE CAPITAL VOTED

VOTES

WITHHELD

1.

To receive and adopt for the annual reports and accounts for the year ended 31 March 2022

 

 

198,891,655

100.00

5,036

0.00

198,896,691

76.22%

748,551

2.

To declare a final dividend in respect of the year ended 31 March 2022

 

 

191,987,046

96.17

7,655,668

3.83

199,642,714

76.51%

2,528

3.

To approve the Directors' remuneration report

 

 

185,769,068

98.34

3,144,427

1.66

188,913,495

72.40%

10,730,076

4.

To re-elect Gill Rider as a Director

 

 

195,296,611

97.83

4,334,126

2.17

199,630,737

76.50%

14,505

5.

To re-elect Susan Davy as a Director

 

 

199,243,756

99.81

386,297

0.19

199,630,053

76.50%

13,518

6.

To re-elect Paul Boote as a Director

 

 

199,377,021

99.87

252,116

0.13

199,629,137

76.50%

14,434

7.

To re-elect Neil Cooper as a Director

 

 

196,356,255

98.36

3,272,354

1.64

199,628,609

76.50%

14,962

8.

To re-elect Iain Evans as a Director

 

 

192,944,501

96.93

6,105,877

3.07

199,050,378

76.28%

593,193

9.

To re-elect Claire Ighodaro as a Director

 

 

196,573,189

98.47

3,055,271

1.53

199,628,460

76.50%

15,111

10.

To re-elect Jon Butterworth as a Director

 

 

196,564,452

98.47

3,063,996

1.53

199,628,448

76.50%

15,123

11.

To re-appoint Ernst & Young LLP as auditor of the Company

 

 

198,301,748

99.33

1,328,880

0.67

199,630,628

76.50%

12,943

12.

To authorise the Audit Committee to determine the remuneration of the auditor on behalf of the Board

 

 

197,300,175

98.83

2,332,324

1.17

199,632,499

76.50%

11,072

13.

To authorise the Company and its subsidiaries to make political donations up to a specified limit

 

 

197,856,264

99.12

1,758,209

0.88

199,614,473

76.50%

29,098

14.

To grant the Directors authority to allot shares

 

 

196,222,456

98.29

3,410,180

1.71

199,632,636

76.50%

10,935

15.

To authorise the general disapplication of pre-emption rights

 

 

198,889,618

99.63

740,472

0.37

199,630,090

76.50%

13,481

16.

To authorise the disapplication of pre-emption rights in connection with an acquisition or specified capital investment

 

 

197,758,437

99.06

1,871,489

0.94

199,629,926

76.50%

13,645

17.

To authorise the market purchase of the Company's shares

 

 

198,299,658

99.38

1,234,967

0.62

199,534,625

76.47%

108,946

18.

To authorise a general meeting other than an AGM to be called on 14 clear days' notice

 

 

188,563,174

94.45

11,076,797

5.55

199,639,971

76.51%

3,600

19.

To consider and approve the Company's climate-related financial disclosures (as set out on pages 106-122 of the Annual Report)

 

183,935,985

94.57

10,551,496

5.43

194,487,481

74.53%

5,156,090

20.

Amendments to the article 5A of the articles of association of the Company

 

199,608,559

99.99

14,787

0.01

199,623,346

76.50%

20,225

 

Notes

 

i) The total votes cast in favour of each resolution include those giving the Chair's discretion.

 

ii) A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of the votes "for" and "against" a resolution.

 

iii) Resolutions 15, 16, 17, 18 and 20 are special resolutions.

 

iv) The total number of ordinary shares of 61.05p in issue at the meeting date, was 260,944,741 ordinary shares, including 5,628 ordinary shares held in treasury. Therefore, the total number of voting rights in the Company as at today's date is 260,939,113 shares.

 

22 July 2022

www.pennon-group.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGEASXAASXAEFA
Date   Source Headline
1st Jul 20267:00 amRNSTotal Voting Rights
22nd Jun 202610:55 amRNSDirector/PDMR Shareholding
18th Jun 20262:53 pmRNSEMTN: Publication of Supplementary Prospectus
16th Jun 20267:00 amRNSPublication of Annual Report and Accounts 2026
10th Jun 20267:00 amRNSFull Year Results 2025/26
1st Jun 20267:00 amRNSTotal Voting Rights
29th May 20262:06 pmRNSHolding(s) in Company
20th May 20261:48 pmRNSDirector/PDMR Shareholding
14th May 202612:03 pmRNSDirector/PDMR Shareholding
6th May 20262:12 pmRNSAdmission to Trading
1st May 20264:31 pmRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20263:11 pmRNSHolding(s) in Company
27th Apr 20264:34 pmRNSHolding(s) in Company
24th Apr 20263:29 pmRNSHolding(s) in Company
22nd Apr 20264:30 pmRNSHolding(s) in Company
21st Apr 20261:17 pmRNSDirector/PDMR Shareholding
20th Apr 20264:09 pmRNSHolding(s) in Company
14th Apr 20264:24 pmRNSRescheduled Full-Year Results Date
1st Apr 20267:00 amRNSTotal Voting Rights
20th Mar 20262:06 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTrading Statement
2nd Mar 20267:00 amRNSTotal Voting Rights
23rd Feb 202612:58 pmRNSDirector/PDMR Shareholding
10th Feb 20267:00 amRNSConfirmation of Chief Executive Officer Start Date
5th Feb 202610:58 amRNSHolding(s) in Company
2nd Feb 20267:01 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSBlock listing Interim Review
23rd Jan 20263:21 pmRNSDirector/PDMR Shareholding
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
23rd Dec 20253:29 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:29 pmRNSDirector/PDMR Shareholding
11th Dec 20251:16 pmRNSConfirmed Financial Calendar
9th Dec 20254:01 pmRNSDirector/PDMR Shareholding
9th Dec 20257:00 amRNSPennon Group CEO Transition Arrangements
1st Dec 20253:42 pmRNSEMTN: Publication of Supplementary Prospectus
1st Dec 20257:00 amRNSTotal Voting Rights
27th Nov 20257:00 amRNSHalf Year Results 2025/26
21st Nov 20254:24 pmRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNSTotal Voting Rights
22nd Oct 20251:26 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSPennon appoints new Non-Executive Director
3rd Oct 20252:19 pmRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSPennon Group appoints Keith Haslett as new CEO
1st Oct 20257:00 amRNSTotal Voting Rights
26th Sep 20257:00 amRNSTrading Statement
23rd Sep 20254:16 pmRNSDirector/PDMR Shareholding
11th Sep 202512:09 pmRNSEMTN Programme: Publication of Final Terms
1st Sep 20257:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.